| Description | Protein intensity values acquired using data-independent acquisition mass spectrometry (DIA-MS). |
| Measurement | protein expression by mass spectrometry |
| Association | gene-cell line associations by differential expression of genes across cell lines |
| Category | proteomics |
| Resource | Sanger Cancer Dependency Map |
| Citation(s) | |
| Last Updated | 2023 Mar 06 |
| Stats |
|
Gene Attribute
Gene Similarity
Attribute Similarity
UMAP
949 sets of proteins associated with cell lines from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
| Gene Set | Description |
|---|---|
| 201T | cell line derived from -666 |
| 22RV1 | cell line derived from Prostate Carcinoma Tumour |
| 23132-87 | cell line derived from Gastric Carcinoma Tumour |
| 42-MG-BA | cell line derived from Glioblastoma Tumour |
| 451Lu | cell line derived from Melanoma Metastasis |
| 5637 | |
| 639-V | cell line derived from Bladder Carcinoma Tumour |
| 647-V | cell line derived from Bladder Carcinoma Tumour |
| 697 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| 769-P | cell line derived from Kidney Carcinoma Tumour |
| 786-0 | This line was derived from a primary clear cell adenocarcinoma. The karyotype is hypertriploid; Y was present in 60% the cells examined. The cells display both microvilli and desmosomes, and can be grown in soft agar. The cells produce a PTH like peptides that is identical to peptides produced by breast and lung tumors. |
| 8-MG-BA | cell line derived from Glioblastoma Tumour |
| 8305C | cell line derived from Thyroid Gland Carcinoma Tumour |
| 8505C | cell line derived from Thyroid Gland Carcinoma Tumour |
| A172 | |
| A204 | |
| A2058 | |
| A253 | cell line derived from Head and Neck Carcinoma Tumour |
| A2780 | |
| A3-KAW | |
| A375 | |
| A388 | cell line derived from Other Solid Cancers Metastasis |
| A4-Fuk | |
| A427 | |
| A431 | |
| A498 | |
| A549 | |
| A673 | |
| A704 | cell line derived from Kidney Carcinoma Tumour |
| ABC-1 | |
| ACHN | |
| AGS | |
| ALL-PO | cell line derived from B-Lymphoblastic Leukemia Tumour |
| ALL-SIL | cell line derived from T-Lymphoblastic Leukemia Tumour |
| AM-38 | |
| AMO-1 | cell line derived from Plasma Cell Myeloma Metastasis |
| AN3-CA | cell line derived from Endometrial Carcinoma Tumour |
| ASH-3 | cell line derived from -666 |
| AsPC-1 | cell line derived from Pancreatic Carcinoma Metastasis |
| ATN-1 | cell line derived from T-Lymphoblastic Leukemia Tumour |
| AU565 | |
| B-CPAP | cell line derived from Thyroid Gland Carcinoma Tumour |
| BALL-1 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| BB30-HNC | |
| BB65-RCC | |
| BC-1 | |
| BC-3 | |
| BE-13 | cell line derived from T-Lymphoblastic Leukemia Tumour |
| BE2-M17 | cell line derived from Neuroblastoma Tumour |
| Becker | |
| BEN | |
| BFTC-905 | cell line derived from Bladder Carcinoma Tumour |
| BFTC-909 | cell line derived from Kidney Carcinoma Tumour |
| BHT-101 | cell line derived from Thyroid Gland Carcinoma Metastasis |
| BHY | cell line derived from Head and Neck Carcinoma Tumour |
| BICR22 | cell line derived from upper aerodigestive tract |
| BICR31 | cell line derived from upper_aerodigestive_tract |
| BICR78 | cell line derived from Oral Cavity Carcinoma Tumour |
| BL-41 | cell line derived from Burkitt's Lymphoma Tumour |
| BONNA-12 | cell line derived from Other Blood Cancers Metastasis |
| BPH-1 | cell line derived from Non-Cancerous Normal |
| BT-20 | cell line derived from Breast Carcinoma Tumour |
| BT-474 | cell line derived from Breast Carcinoma Tumour |
| BT-483 | cell line derived from Breast Carcinoma Tumour |
| BT-549 | cell line derived from Breast Carcinoma Tumour |
| BV-173 | cell line derived from Chronic Myelogenous Leukemia Tumour |
| BxPC-3 | Human pancreatic adenocarcinoma cell line, established from a 61 year old human female. |
| C-33-A | cell line derived from Cervical Carcinoma Tumour |
| C-4-I | cell line derived from Cervical Carcinoma Tumour |
| C2BBe1 | |
| C32 | cell line derived from Melanoma Tumour |
| C3A | |
| Ca-Ski | cell line derived from Cervical Carcinoma Metastasis |
| CA46 | |
| Ca9-22 | cell line derived from Oral Cavity Carcinoma Tumour |
| CADO-ES1 | cell line derived from Ewing's Sarcoma Metastasis |
| CAKI-1 | cell line derived from Kidney Carcinoma Metastasis |
| CAL-120 | cell line derived from Breast Carcinoma Metastasis |
| CAL-12T | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| CAL-148 | cell line derived from Breast Carcinoma Metastasis |
| CAL-27 | cell line derived from Oral Cavity Carcinoma Tumour |
| CAL-29 | cell line derived from Bladder Carcinoma Tumour |
| CAL-33 | cell line derived from Oral Cavity Carcinoma Tumour |
| CAL-39 | cell line derived from Other Solid Cancers Tumour |
| CAL-51 | cell line derived from Breast Carcinoma Metastasis |
| CAL-54 | cell line derived from Kidney Carcinoma Metastasis |
| CAL-62 | cell line derived from Thyroid Gland Carcinoma Tumour |
| CAL-72 | cell line derived from Osteosarcoma Tumour |
| CAL-78 | cell line derived from Chondrosarcoma Tumour |
| Calu-3 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| Calu-6 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| CAMA-1 | cell line derived from Breast Carcinoma Metastasis |
| Caov-3 | cell line derived from Ovarian Carcinoma Tumour |
| Caov-4 | cell line derived from Ovarian Carcinoma Metastasis |
| CAPAN-1 | cell line derived from Pancreatic Carcinoma Metastasis |
| CAPAN-2 | cell line derived from Pancreatic Carcinoma Tumour |
| CaR-1 | cell line derived from Colorectal Carcinoma Tumour |
| CAS-1 | cell line derived from Glioblastoma Tumour |
| CCK-81 | cell line derived from Colorectal Carcinoma Tumour |
| CCRF-CEM | cell line derived from T-Lymphoblastic Leukemia Tumour |
| CFPAC-1 | cell line derived from Pancreatic Carcinoma Metastasis |
| CGTH-W-1 | cell line derived from Thyroid Gland Carcinoma Tumour |
| ChaGo-K-1 | cell line derived from Other Solid Cancers Tumour |
| CHL-1 | cell line derived from Melanoma Metastasis |
| CHP-126 | cell line derived from Neuroblastoma Tumour |
| CHP-212 | cell line derived from Neuroblastoma Tumour |
| CHSA0011 | cell line derived from -666 |
| CHSA0108 | cell line derived from -666 |
| CHSA8926 | cell line derived from -666 |
| CL-11 | cell line derived from Colorectal Carcinoma Tumour |
| CML-T1 | cell line derived from Chronic Myelogenous Leukemia Tumour |
| COLO-205 | cell line derived from Colorectal Carcinoma Metastasis |
| COLO-320-HSR | cell line derived from Colorectal Carcinoma Tumour |
| COLO-668 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| COLO-678 | cell line derived from Colorectal Carcinoma Metastasis |
| COLO-679 | cell line derived from Melanoma Tumour |
| COLO-680N | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| COLO-684 | cell line derived from Endometrial Carcinoma Tumour |
| COLO-783 | cell line derived from Melanoma Metastasis |
| COLO-792 | cell line derived from Melanoma Metastasis |
| COLO-800 | cell line derived from Melanoma Tumour |
| COLO-824 | cell line derived from Breast Carcinoma Metastasis |
| COLO-829 | cell line derived from Melanoma Tumour |
| COR-L105 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| COR-L23 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| COR-L279 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| COR-L303 | cell line derived from -666 |
| COR-L311 | cell line derived from Small Cell Lung Carcinoma Tumour |
| COR-L32 | cell line derived from -666 |
| COR-L321 | cell line derived from -666 |
| COR-L88 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| COR-L95 | cell line derived from Small Cell Lung Carcinoma Tumour |
| CP50-MEL-B | cell line derived from skin |
| CP66-MEL | |
| CPC-N | cell line derived from Small Cell Lung Carcinoma Metastasis |
| CRO-AP2 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Tumour |
| CS1 | cell line derived from -666 |
| CTB-1 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Tumour |
| CTV-1 | cell line derived from T-Lymphoblastic Leukemia Unknown |
| CW-2 | cell line derived from Colorectal Carcinoma Tumour |
| D-245MG | cell line derived from central_nervous_system |
| D-247MG | |
| D-263MG | |
| D-283MED | cell line derived from Other Solid Cancers Metastasis |
| D-336MG | |
| D-392MG | |
| D-423MG | |
| D-502MG | |
| D-542MG | |
| D-566MG | |
| DAN-G | cell line derived from Pancreatic Carcinoma Tumour |
| Daoy | The Daoy cell line was established in 1985 by P. F Jacobsen of the Royal Perth Hospital in Western Australia. The line was derived from biopsy material taken from a tumor in the posterior fossa of a 4 year old boy. |
| Daudi | |
| DB | cell line derived from B-Cell Non-Hodgkin's Lymphoma Tumour |
| DBTRG-05MG | cell line derived from Glioblastoma Tumour |
| DEL | |
| Detroit562 | |
| DG-75 | cell line derived from Burkitt's Lymphoma Metastasis |
| DiFi | cell line derived from -666 |
| DJM-1 | cell line derived from Other Solid Cancers Tumour |
| DK-MG | cell line derived from Glioblastoma Tumour |
| DMS-114 | cell line derived from Small Cell Lung Carcinoma Tumour |
| DMS-273 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| DMS-53 | cell line derived from Small Cell Lung Carcinoma Tumour |
| DMS-79 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| DND-41 | cell line derived from T-Lymphoblastic Leukemia Tumour |
| DOHH-2 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| DOK | |
| DoTc2-4510 | cell line derived from Cervical Carcinoma Tumour |
| DOV13 | cell line derived from Ovarian Carcinoma Unknown |
| DSH1 | |
| DU-145 | cell line derived from Prostate Carcinoma Metastasis |
| DU-4475 | cell line derived from Breast Carcinoma Metastasis |
| EB-3 | cell line derived from Burkitt's Lymphoma Tumour |
| EB2 | |
| EBC-1 | cell line derived from Squamous Cell Lung Carcinoma Tumour |
| EC-GI-10 | cell line derived from Esophageal Squamous Cell Carcinoma Metastasis |
| ECC10 | cell line derived from Gastric Carcinoma Metastasis |
| ECC12 | cell line derived from Gastric Carcinoma Tumour |
| EFM-19 | cell line derived from Breast Carcinoma Metastasis |
| EFM-192A | cell line derived from Breast Carcinoma Metastasis |
| EFO-21 | cell line derived from Ovarian Carcinoma Metastasis |
| EFO-27 | cell line derived from Ovarian Carcinoma Metastasis |
| EJM | cell line derived from haematopoietic_and_lymphoid_tissue |
| EKVX | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| EM-2 | cell line derived from Chronic Myelogenous Leukemia Tumour |
| EMC-BAC-1 | cell line derived from -666 |
| EMC-BAC-2 | cell line derived from -666 |
| EN | cell line derived from Endometrial Carcinoma Tumour |
| EoL-1-cell | cell line derived from Acute Myeloid Leukemia Tumour |
| EPLC-272H | cell line derived from Other Solid Cancers Tumour |
| ES-2 | cell line derived from Ovarian Carcinoma Tumour |
| ES1 | |
| ES4 | cell line derived from bone |
| ES5 | |
| ES6 | |
| ES7 | |
| ES8 | |
| ESO26 | cell line derived from -666 |
| ESO51 | cell line derived from -666 |
| ESS-1 | cell line derived from Other Sarcomas Tumour |
| ETK-1 | |
| EVSA-T | cell line derived from Breast Carcinoma Metastasis |
| EW-1 | |
| EW-11 | |
| EW-12 | |
| EW-13 | |
| EW-16 | |
| EW-18 | |
| EW-22 | |
| EW-24 | |
| EW-3 | |
| EW-7 | |
| FADU | Cell line derived from squamous cell carcinoma of the hypopharynx. |
| Farage | cell line derived from B-Cell Non-Hodgkin's Lymphoma Tumour |
| FLO-1 | cell line derived from Esophageal Carcinoma Tumour |
| FTC-133 | cell line derived from Thyroid Gland Carcinoma Metastasis |
| FU-OV-1 | cell line derived from Ovarian Carcinoma Tumour |
| FU97 | |
| G-292-Clone-A141B1 | cell line derived from Osteosarcoma Tumour |
| G-361 | cell line derived from Melanoma Tumour |
| G-401 | cell line derived from Other Solid Cancers Tumour |
| G-402 | cell line derived from Other Sarcomas Tumour |
| G-MEL | cell line derived from -666 |
| GA-10 | cell line derived from Burkitt's Lymphoma Tumour |
| GAK | cyclin G associated kinase|In all eukaryotes, the cell cycle is governed by cyclin-dependent protein kinases (CDKs), whose activities are regulated by cyclins and CDK inhibitors in a diverse array of mechanisms that involve the control of phosphorylation and dephosphorylation of Ser, Thr or Tyr residues. Cyclins are molecules that possess a consensus domain called the 'cyclin box.' In mammalian cells, 9 cyclin species have been identified, and they are referred to as cyclins A through I. Cyclin G is a direct transcriptional target of the p53 tumor suppressor gene product and thus functions downstream of p53. GAK is an association partner of cyclin G and CDK5. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013] |
| GAMG | cell line derived from Glioblastoma Tumour |
| GB-1 | cell line derived from Glioblastoma Tumour |
| GCIY | cell line derived from Gastric Carcinoma Tumour |
| GCT | A Giant Cell Tumor (GCT) cell line derived from a human fibrous histiocytoma lung metastasis |
| GDM-1 | cell line derived from Acute Myeloid Leukemia Tumour |
| GI-1 | cell line derived from Glioblastoma Tumour |
| GI-ME-N | cell line derived from Neuroblastoma Metastasis |
| GOTO | |
| GP5d | cell line derived from Colorectal Carcinoma Tumour |
| GR-ST | cell line derived from B-Lymphoblastic Leukemia Tumour |
| GRANTA-519 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Tumour |
| H-EMC-SS | cell line derived from Chondrosarcoma Tumour |
| H3255 | cell line derived from Non-Small Cell Lung Carcinoma Unknown |
| H4 | |
| H9 | |
| HA7-RCC | cell line derived from kidney |
| HAL-01 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| HARA | cell line derived from lung |
| HC-1 | cell line derived from Other Blood Cancers Tumour |
| HCC-15 | cell line derived from Squamous Cell Lung Carcinoma Tumour |
| HCC-33 | cell line derived from Small Cell Lung Carcinoma Tumour |
| HCC-366 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| HCC-78 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| HCC-827 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| HCC1143 | cell line derived from Breast Carcinoma Tumour |
| HCC1187 | cell line derived from Breast Carcinoma Tumour |
| HCC1395 | |
| HCC1419 | cell line derived from Breast Carcinoma Tumour |
| HCC1428 | cell line derived from Breast Carcinoma Metastasis |
| HCC1500 | cell line derived from Breast Carcinoma Tumour |
| HCC1569 | cell line derived from Breast Carcinoma Tumour |
| HCC1599 | cell line derived from Breast Carcinoma Tumour |
| HCC1806 | |
| HCC1937 | |
| HCC1954 | |
| HCC2157 | cell line derived from Breast Carcinoma Tumour |
| HCC2218 | cell line derived from Breast Carcinoma Tumour |
| HCC2998 | |
| HCC38 | |
| HCC70 | cell line derived from Breast Carcinoma Tumour |
| HCE-4 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| HCT-116 | cell line derived from Colorectal Carcinoma Tumour |
| HCT-15 | cell line derived from Colorectal Carcinoma Tumour |
| HDLM-2 | cell line derived from Hodgkin's Lymphoma Metastasis |
| HDQ-P1 | cell line derived from Breast Carcinoma Tumour |
| HEC-1 | |
| HEL | |
| HeLa | |
| Hep3B2-1-7 | cell line derived from Hepatocellular Carcinoma Tumour |
| Hey | |
| HGC-27 | cell line derived from Gastric Carcinoma Metastasis |
| HH | cell line derived from T-Cell Non-Hodgkin's Lymphoma Tumour |
| HL-60 | HL-60 is a cell line which is the bearer of human acute myeloid leukemia established from the peripheral blood of a 35-year-old woman with acute myeloid leukemia (AML FAB M2) in 1976.|Human acute myeloid leukemia established from the peripheral blood of a 35-year-old woman with acute myeloid leukemia (AML FAB M2) in 1976. |
| HLE | |
| HMV-II | cell line derived from Melanoma Tumour |
| HO-1-N-1 | |
| HO-1-u-1 | cell line derived from Oral Cavity Carcinoma Tumour |
| HOP-62 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| HOP-92 | cell line derived from Non-Small Cell Lung Carcinoma Unknown |
| HOS | |
| HPAC | |
| Hs-445 | cell line derived from Non-Cancerous Tumour |
| Hs-578-T | cell line derived from Breast Carcinoma Tumour |
| Hs-633T | cell line derived from Other Sarcomas Tumour |
| Hs-683 | cell line derived from Glioma Tumour |
| Hs-746T | cell line derived from Gastric Carcinoma Metastasis |
| Hs-766T | cell line derived from Pancreatic Carcinoma Metastasis |
| Hs-939-T | cell line derived from Melanoma Tumour |
| Hs-940-T | cell line derived from Melanoma Tumour |
| HSC-2 | cell line derived from Oral Cavity Carcinoma Tumour |
| HSC-3 | cell line derived from Oral Cavity Carcinoma Tumour |
| HSC-39 | cell line derived from -666 |
| HSC-4 | cell line derived from Oral Cavity Carcinoma Tumour |
| HT | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| HT-1080 | cell line derived from Other Sarcomas Tumour |
| HT-115 | cell line derived from Colorectal Carcinoma Tumour |
| HT-1197 | cell line derived from Bladder Carcinoma Tumour |
| HT-1376 | cell line derived from Bladder Carcinoma Tumour |
| HT-144 | cell line derived from Melanoma Tumour |
| HT-29 | |
| HT-3 | cell line derived from Cervical Carcinoma Metastasis |
| HT55 | cell line derived from Colorectal Carcinoma Tumour |
| HTC-C3 | cell line derived from Thyroid Gland Carcinoma Metastasis |
| HuCCT1 | |
| huH-1 | cell line derived from Hepatocellular Carcinoma Tumour |
| HuH-7 | HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. HuH-7 is an immortal cell line of epithelial-like tumorigenic cells. It usually grow in 2D monolayers. |
| HuO-3N1 | cell line derived from Osteosarcoma Tumour |
| HuO9 | |
| HuP-T3 | |
| HuP-T4 | cell line derived from Pancreatic Carcinoma Metastasis |
| HuTu-80 | cell line derived from Other Solid Cancers Tumour |
| IA-LM | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| IGR-1 | cell line derived from Melanoma Metastasis |
| IGR-37 | cell line derived from Melanoma Metastasis |
| IGROV-1 | |
| IHH-4 | cell line derived from -666 |
| IM-9 | cell line derived from Non-Cancerous Normal |
| IM-95 | cell line derived from Gastric Carcinoma Tumour |
| IMR-5 | cell line derived from Neuroblastoma Metastasis |
| IPC-298 | cell line derived from Melanoma Tumour |
| IST-MEL1 | cell line derived from Melanoma Tumour |
| IST-MES1 | cell line derived from Mesothelioma Tumour |
| IST-SL1 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| IST-SL2 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| J82 | |
| JAR | |
| JEG-3 | cell line derived from Other Solid Cancers Tumour |
| JEKO-1 | |
| JHH-1 | cell line derived from Hepatocellular Carcinoma Tumour |
| JHH-2 | cell line derived from Hepatocellular Carcinoma Unknown |
| JHH-4 | cell line derived from Hepatocellular Carcinoma Tumour |
| JHH-6 | cell line derived from Hepatocellular Carcinoma Tumour |
| JHH-7 | cell line derived from Hepatocellular Carcinoma Tumour |
| JHOS-2 | cell line derived from Ovarian Carcinoma Tumour |
| JHOS-3 | cell line derived from Ovarian Carcinoma Tumour |
| JHOS-4 | cell line derived from Ovarian Carcinoma Tumour |
| JHU-011 | cell line derived from Head and Neck Carcinoma Unknown |
| JHU-022 | cell line derived from Oral Cavity Carcinoma Unknown |
| JHU-029 | cell line derived from Head and Neck Carcinoma Tumour |
| JIMT-1 | |
| JiyoyeP-2003 | |
| JJN-3 | cell line derived from Plasma Cell Myeloma Tumour |
| JM1 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| JSC-1 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| Jurkat | |
| JURL-MK1 | cell line derived from Chronic Myelogenous Leukemia Tumour |
| JVM-2 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Tumour |
| JVM-3 | cell line derived from Other Blood Cancers Tumour |
| K-562 | cell line derived from Chronic Myelogenous Leukemia Metastasis |
| K052 | cell line derived from Acute Myeloid Leukemia Tumour |
| K2 | cell line derived from -666 |
| K5 | |
| KALS-1 | |
| KARPAS-1106P | cell line derived from lymph node |
| KARPAS-231 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| KARPAS-299 | cell line derived from T-Cell Non-Hodgkin's Lymphoma Tumour |
| KARPAS-422 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| KARPAS-45 | cell line derived from T-Lymphoblastic Leukemia Tumour |
| KARPAS-620 | cell line derived from Plasma Cell Myeloma Tumour |
| KASUMI-1 | cell line derived from Acute Myeloid Leukemia Tumour |
| KATOIII | |
| KCL-22 | cell line derived from Chronic Myelogenous Leukemia Metastasis |
| KE-37 | cell line derived from T-Lymphoblastic Leukemia Tumour |
| KELLY | cell line derived from Neuroblastoma Tumour |
| KG-1 | cell line derived from Acute Myeloid Leukemia Tumour |
| KGN | |
| KINGS-1 | |
| KLE | |
| KM-H2 | cell line derived from Hodgkin's Lymphoma Metastasis |
| KM12 | cell line derived from Colorectal Carcinoma Tumour |
| KMH-2 | cell line derived from Thyroid Gland Carcinoma Tumour |
| KMOE-2 | cell line derived from Acute Myeloid Leukemia Tumour |
| KMRC-1 | cell line derived from Kidney Carcinoma Tumour |
| KMRC-20 | cell line derived from Kidney Carcinoma Tumour |
| KMS-11 | KMS-11 cell line was derived from four patients with multiple myeloma. These cells represent a later stage of B-cell differentiation, and shows characteristics of plasma cells by secreting surface kappa chain immunoglobulins. |
| KMS-12-BM | cell line derived from Plasma Cell Myeloma Tumour |
| KNS-42 | |
| KNS-62 | |
| KNS-81-FD | |
| KON | cell line derived from -666 |
| KOPN-8 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| KOSC-2 | |
| KP-1N | cell line derived from Pancreatic Carcinoma Unknown |
| KP-2 | cell line derived from Pancreatic Carcinoma Tumour |
| KP-3 | cell line derived from Pancreatic Carcinoma Metastasis |
| KP-4 | cell line derived from Pancreatic Carcinoma Metastasis |
| KP-N-RT-BM-1 | |
| KP-N-YN | cell line derived from Neuroblastoma Metastasis |
| KP-N-YS | |
| KS-1 | |
| KU-19-19 | cell line derived from Bladder Carcinoma Tumour |
| KU812 | |
| KURAMOCHI | |
| KY821 | |
| KYAE-1 | cell line derived from -666 |
| KYM-1 | cell line derived from Rhabdomyosarcoma Tumour |
| KYSE-140 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| KYSE-150 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| KYSE-180 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| KYSE-220 | cell line derived from -666 |
| KYSE-270 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| KYSE-410 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| KYSE-450 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| KYSE-50 | cell line derived from -666 |
| KYSE-510 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| KYSE-520 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| KYSE-70 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| L-1236 | cell line derived from Hodgkin's Lymphoma Tumour |
| L-363 | cell line derived from Plasma Cell Myeloma Tumour |
| L-428 | cell line derived from Hodgkin's Lymphoma Metastasis |
| L-540 | cell line derived from Hodgkin's Lymphoma Tumour |
| LAMA-84 | cell line derived from Chronic Myelogenous Leukemia Tumour |
| LAN-6 | |
| LB1047-RCC | |
| LB2241-RCC | |
| LB2518-MEL | |
| LB373-MEL-D | |
| LB647-SCLC | |
| LB771-HNC | |
| LB831-BLC | |
| LB996-RCC | |
| LC-1-sq | cell line derived from Squamous Cell Lung Carcinoma Tumour |
| LC-2-ad | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| LC4-1 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| LCLC-103H | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| LCLC-97TM1 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| LK-2 | cell line derived from Squamous Cell Lung Carcinoma Tumour |
| LN-18 | cell line derived from Glioblastoma Tumour |
| LN-229 | cell line derived from Glioblastoma Tumour |
| LN-405 | cell line derived from Glioblastoma Tumour |
| LNCaP-Clone-FGC | cell line derived from Prostate Carcinoma Metastasis |
| LNZTA3WT4 | cell line derived from Glioma Tumour |
| LOU-NH91 | cell line derived from Squamous Cell Lung Carcinoma Tumour |
| LOUCY | |
| LoVo | |
| LOXIMVI | cell line derived from Melanoma Metastasis |
| LP-1 | cell line derived from Plasma Cell Myeloma Tumour |
| LS-123 | |
| LS-180 | cell line derived from Colorectal Carcinoma Tumour |
| LS-411N | cell line derived from Colorectal Carcinoma Tumour |
| LS-513 | cell line derived from Colorectal Carcinoma Tumour |
| LS1034 | cell line derived from Colorectal Carcinoma Tumour |
| LU-134-A | cell line derived from Small Cell Lung Carcinoma Tumour |
| LU-135 | cell line derived from Small Cell Lung Carcinoma Tumour |
| LU-139 | cell line derived from Small Cell Lung Carcinoma Tumour |
| LU-165 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| LU-65 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| LU-99A | |
| LXF-289 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| M059J | cell line derived from Glioblastoma Tumour |
| MC-IXC | cell line derived from Ewing's Sarcoma Metastasis |
| MC116 | |
| MCF7 | cell line derived from Breast Carcinoma Metastasis |
| MDA-MB-157 | cell line derived from Breast Carcinoma Metastasis |
| MDA-MB-175-VII | cell line derived from Breast Carcinoma Metastasis |
| MDA-MB-231 | cell line derived from Breast Carcinoma Metastasis |
| MDA-MB-330 | cell line derived from Breast Carcinoma Metastasis |
| MDA-MB-361 | cell line derived from Breast Carcinoma Metastasis |
| MDA-MB-415 | cell line derived from Breast Carcinoma Metastasis |
| MDA-MB-436 | cell line derived from Breast Carcinoma Metastasis |
| MDA-MB-453 | cell line derived from Breast Carcinoma Metastasis |
| MDA-MB-468 | cell line derived from Breast Carcinoma Metastasis |
| MDST8 | cell line derived from large_intestine |
| ME-1 | cell line derived from Acute Myeloid Leukemia Tumour |
| ME-180 | cell line derived from Cervical Carcinoma Metastasis |
| MEG-01 | cell line derived from Chronic Myelogenous Leukemia Tumour |
| MEL-HO | cell line derived from Melanoma Tumour |
| MEL-JUSO | cell line derived from Melanoma Tumour |
| MES-SA | cell line derived from Other Sarcomas Tumour |
| Mewo | |
| MFE-280 | cell line derived from Endometrial Carcinoma Tumour |
| MFE-296 | cell line derived from Endometrial Carcinoma Tumour |
| MFE-319 | cell line derived from Endometrial Carcinoma Tumour |
| MFH-ino | cell line derived from Other Sarcomas Tumour |
| MFM-223 | cell line derived from Breast Carcinoma Metastasis |
| MG-63 | cell line derived from Osteosarcoma Tumour |
| MHH-CALL-4 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| MHH-ES-1 | cell line derived from Ewing's Sarcoma Metastasis |
| MHH-NB-11 | cell line derived from Neuroblastoma Metastasis |
| MHH-PREB-1 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Tumour |
| MIA-PaCa-2 | cell line derived from Pancreatic Carcinoma Tumour |
| MKN28 | Well differentiated human gastric adenocarcinoma cell line. |
| MKN45 | Human gastric adenocarcinoma, established from the poorly differentiated adenocarcinoma of the stomach (medullary type) of a 62-year-old woman. |
| MKN7 | Well differentiated human gastric adenocarcinoma cell line. |
| ML-1 | cell line derived from Thyroid Gland Carcinoma Tumour |
| ML-2 | cell line derived from Acute Myeloid Leukemia Tumour |
| MLMA | cell line derived from haematopoietic_and_lymphoid_tissue |
| MM1S | cell line derived from Plasma Cell Myeloma Tumour |
| MMAc-SF | |
| MN-60 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| Mo-T | cell line derived from Other Blood Cancers Tumour |
| MOG-G-CCM | cell line derived from Glioma Tumour |
| MOG-G-UVW | cell line derived from Glioma Tumour |
| MOLM-13 | cell line derived from Acute Myeloid Leukemia Tumour |
| MOLM-16 | cell line derived from Acute Myeloid Leukemia Tumour |
| MOLP-8 | cell line derived from Plasma Cell Myeloma Tumour |
| MOLT-13 | cell line derived from T-Lymphoblastic Leukemia Tumour |
| MOLT-16 | cell line derived from T-Lymphoblastic Leukemia Tumour |
| MOLT-4 | |
| MONO-MAC-6 | cell line derived from Acute Myeloid Leukemia Tumour |
| MPP-89 | cell line derived from Mesothelioma Tumour |
| MRK-nu-1 | cell line derived from Breast Carcinoma Tumour |
| MS-1 | cell line derived from Small Cell Lung Carcinoma Tumour |
| MS751 | cell line derived from Cervical Carcinoma Metastasis |
| MSTO-211H | cell line derived from Mesothelioma Metastasis |
| MV-4-11 | cell line derived from Acute Myeloid Leukemia Tumour |
| MY-M12 | cell line derived from -666 |
| MZ1-PC | cell line derived from pancreas |
| MZ2-MEL | |
| MZ7-mel | |
| NALM-6 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| NAMALWA | |
| NB(TU)1-10 | cell line derived from -666 |
| NB1 | |
| NB10 | |
| NB12 | |
| NB13 | |
| NB14 | cell line derived from Neuroblastoma Metastasis |
| NB17 | |
| NB4 | |
| NB5 | cell line derived from Neuroblastoma Metastasis |
| NB6 | |
| NB69 | cell line derived from Neuroblastoma Tumour |
| NB7 | cell line derived from Neuroblastoma Metastasis |
| NCC010 | cell line derived from -666 |
| NCC021 | cell line derived from -666 |
| NCCIT | |
| NCI-H1048 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H1092 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H1105 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H1155 | |
| NCI-H1299 | |
| NCI-H1304 | cell line derived from Small Cell Lung Carcinoma Unknown |
| NCI-H1341 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H1355 | |
| NCI-H1435 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H1436 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H1437 | |
| NCI-H146 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H1563 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H1568 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1573 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1581 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H1623 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1648 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1650 | |
| NCI-H1651 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H1666 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1688 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H1693 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1694 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H1703 | |
| NCI-H1734 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H1755 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1770 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1781 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1792 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1793 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H1836 | cell line derived from Small Cell Lung Carcinoma Tumour |
| NCI-H1838 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H1876 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H1915 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H1944 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H196 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H1963 | cell line derived from Small Cell Lung Carcinoma Tumour |
| NCI-H1975 | |
| NCI-H1993 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H2009 | |
| NCI-H2023 | cell line derived from Squamous Cell Lung Carcinoma Metastasis |
| NCI-H2029 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H2030 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H2052 | cell line derived from Mesothelioma Metastasis |
| NCI-H2066 | cell line derived from Squamous Cell Lung Carcinoma Tumour |
| NCI-H2081 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H2085 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H2087 | |
| NCI-H209 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H211 | cell line derived from Small Cell Lung Carcinoma Tumour |
| NCI-H2110 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H2122 | |
| NCI-H2135 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H2141 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H2170 | |
| NCI-H2171 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H2172 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H2227 | cell line derived from Small Cell Lung Carcinoma Tumour |
| NCI-H2228 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H226 | |
| NCI-H2291 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H23 | |
| NCI-H2342 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H2347 | |
| NCI-H2369 | cell line derived from lung |
| NCI-H2373 | cell line derived from lung |
| NCI-H2405 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H2444 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H2452 | cell line derived from Mesothelioma Tumour |
| NCI-H2461 | cell line derived from lung |
| NCI-H250 | cell line derived from Small Cell Lung Carcinoma Tumour |
| NCI-H2591 | cell line derived from Mesothelioma Unknown |
| NCI-H2595 | cell line derived from lung |
| NCI-H2722 | cell line derived from lung |
| NCI-H2731 | cell line derived from Mesothelioma Unknown |
| NCI-H2795 | cell line derived from lung |
| NCI-H28 | cell line derived from Mesothelioma Metastasis |
| NCI-H2803 | cell line derived from lung |
| NCI-H2804 | cell line derived from lung |
| NCI-H2810 | cell line derived from lung |
| NCI-H2818 | cell line derived from Mesothelioma Unknown |
| NCI-H2869 | cell line derived from Mesothelioma Unknown |
| NCI-H290 | cell line derived from Mesothelioma Unknown |
| NCI-H292 | cell line derived from Other Solid Cancers Metastasis |
| NCI-H3118 | cell line derived from Head and Neck Carcinoma Unknown |
| NCI-H3122 | cell line derived from lung |
| NCI-H322M | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H345 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H358 | |
| NCI-H441 | |
| NCI-H446 | |
| NCI-H460 | |
| NCI-H508 | cell line derived from Colorectal Carcinoma Metastasis |
| NCI-H510A | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H513 | cell line derived from Non-Small Cell Lung Carcinoma Unknown |
| NCI-H520 | |
| NCI-H522 | |
| NCI-H524 | |
| NCI-H526 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H596 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H64 | |
| NCI-H647 | cell line derived from Non-Small Cell Lung Carcinoma Metastasis |
| NCI-H650 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H660 | cell line derived from Prostate Carcinoma Metastasis |
| NCI-H661 | |
| NCI-H69 | Human Caucasian lung small cell carcinoma cell line. |
| NCI-H716 | |
| NCI-H720 | cell line derived from Other Solid Cancers Tumour |
| NCI-H727 | cell line derived from Other Solid Cancers Tumour |
| NCI-H740 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H747 | cell line derived from Colorectal Carcinoma Metastasis |
| NCI-H748 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H810 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| NCI-H82 | |
| NCI-H838 | |
| NCI-H847 | cell line derived from Small Cell Lung Carcinoma Metastasis |
| NCI-H929 | cell line derived from Plasma Cell Myeloma Metastasis |
| NCI-N87 | |
| NEC8 | cell line derived from Other Solid Cancers Tumour |
| NH-12 | cell line derived from Neuroblastoma Tumour |
| NK-92MI | cell line derived from Other Blood Cancers Tumour |
| NKM-1 | |
| NMC-G1 | |
| no-10 | |
| no-11 | |
| NOMO-1 | |
| NOS-1 | cell line derived from Osteosarcoma Tumour |
| NTERA-2-cl-D1 | cell line derived from Other Solid Cancers Metastasis |
| NU-DUL-1 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| NUGC-3 | cell line derived from Gastric Carcinoma Metastasis |
| NUGC-4 | cell line derived from Gastric Carcinoma Metastasis |
| NY | |
| OACM5-1 | cell line derived from -666 |
| OACp4C | cell line derived from -666 |
| OAW-28 | cell line derived from Ovarian Carcinoma Metastasis |
| OAW-42 | cell line derived from Ovarian Carcinoma Metastasis |
| OC-314 | cell line derived from Ovarian Carcinoma Metastasis |
| OCI-AML2 | cell line derived from Acute Myeloid Leukemia Tumour |
| OCI-AML5 | cell line derived from Acute Myeloid Leukemia Tumour |
| OCI-LY-19 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Tumour |
| OCI-LY7 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Tumour |
| OCI-M1 | cell line derived from Acute Myeloid Leukemia Tumour |
| OCUB-M | cell line derived from Breast Carcinoma Metastasis |
| OCUM-1 | cell line derived from Gastric Carcinoma Tumour |
| OE19 | cell line derived from Esophageal Carcinoma Tumour |
| OE21 | |
| OE33 | |
| OMC-1 | cell line derived from Cervical Carcinoma Metastasis |
| ONS-76 | |
| OPM-2 | cell line derived from Plasma Cell Myeloma Tumour |
| OS-RC-2 | cell line derived from Kidney Carcinoma Tumour |
| OSC-19 | cell line derived from -666 |
| OSC-20 | cell line derived from -666 |
| OV-17R | cell line derived from ovary |
| OV-56 | cell line derived from Ovarian Carcinoma Metastasis |
| OV-7 | cell line derived from Ovarian Carcinoma Tumour |
| OV-90 | cell line derived from Ovarian Carcinoma Metastasis |
| OVCA420 | cell line derived from Ovarian Carcinoma Tumour |
| OVCA433 | cell line derived from Ovarian Carcinoma Tumour |
| OVCAR-3 | cell line derived from Ovarian Carcinoma Metastasis |
| OVCAR-4 | cell line derived from Ovarian Carcinoma Tumour |
| OVCAR-5 | cell line derived from Ovarian Carcinoma Unknown |
| OVCAR-8 | cell line derived from Ovarian Carcinoma Tumour |
| OVISE | cell line derived from Ovarian Carcinoma Metastasis |
| OVK-18 | cell line derived from Ovarian Carcinoma Metastasis |
| OVKATE | cell line derived from Ovarian Carcinoma Tumour |
| OVMIU | cell line derived from -666 |
| OVTOKO | cell line derived from Ovarian Carcinoma Metastasis |
| P12-ICHIKAWA | cell line derived from T-Lymphoblastic Leukemia Tumour |
| P30-OHK | cell line derived from B-Lymphoblastic Leukemia Tumour |
| P31-FUJ | |
| P32-ISH | cell line derived from -666 |
| PA-1 | cell line derived from Ovarian Carcinoma Metastasis |
| PA-TU-8902 | cell line derived from Pancreatic Carcinoma Tumour |
| PA-TU-8988T | cell line derived from Pancreatic Carcinoma Metastasis |
| PANC-02-03 | cell line derived from Pancreatic Carcinoma Tumour |
| PANC-03-27 | cell line derived from Pancreatic Carcinoma Tumour |
| PANC-04-03 | cell line derived from Pancreatic Carcinoma Tumour |
| PANC-08-13 | cell line derived from Pancreatic Carcinoma Tumour |
| PANC-10-05 | cell line derived from Pancreatic Carcinoma Tumour |
| PC-14 | |
| PC-3 | Human prostate carcinoma cell line; established from the bone marrow metastasis isolated post-mortem from a 62-year-old Caucasian man with grade IV prostate cancer, poorly differentiated adenocarcinoma, after androgen suppression therapy; described to form tumors in nude mice, to grow in soft agar, and to be unresponsive to androgen treatment. |
| PC-3_[JPC-3] | cell line derived from -666 |
| PCI-15A | cell line derived from -666 |
| PCI-30 | cell line derived from -666 |
| PCI-4B | cell line derived from -666 |
| PCI-6A | cell line derived from -666 |
| PE-CA-PJ15 | cell line derived from Oral Cavity Carcinoma Tumour |
| PEO1 | |
| PF-382 | cell line derived from T-Lymphoblastic Leukemia Metastasis |
| PFSK-1 | cell line derived from Other Solid Cancers Tumour |
| PL-21 | cell line derived from Acute Myeloid Leukemia Tumour |
| PL4 | cell line derived from -666 |
| PSN1 | cell line derived from Pancreatic Carcinoma Tumour |
| PWR-1E | cell line derived from Non-Cancerous Normal |
| QGP-1 | cell line derived from Other Solid Cancers Tumour |
| QIMR-WIL | cell line derived from Acute Myeloid Leukemia Tumour |
| Raji | |
| Ramos-2G6-4C10 | cell line derived from Burkitt's Lymphoma Tumour |
| RCC-AB | cell line derived from kidney |
| RCC-ER | cell line derived from kidney |
| RCC-FG2 | cell line derived from kidney |
| RCC-JF | cell line derived from kidney |
| RCC-JW | cell line derived from kidney |
| RCC-MF | cell line derived from kidney |
| RCC10RGB | cell line derived from Kidney Carcinoma Tumour |
| RCH-ACV | cell line derived from B-Lymphoblastic Leukemia Tumour |
| RCM-1 | |
| RD | |
| REH | |
| RERF-GC-1B | cell line derived from Gastric Carcinoma Metastasis |
| RERF-LC-KJ | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| RERF-LC-MS | |
| RERF-LC-Sq1 | cell line derived from Squamous Cell Lung Carcinoma Tumour |
| RF-48 | cell line derived from stomach |
| RH-1 | cell line derived from Ewing's Sarcoma Metastasis |
| RH-18 | cell line derived from Rhabdomyosarcoma Tumour |
| RH-41 | cell line derived from Rhabdomyosarcoma Tumour |
| RKN | cell line derived from soft_tissue |
| RKO | |
| RL | |
| RL95-2 | cell line derived from Endometrial Carcinoma Tumour |
| RMG-I | cell line derived from Ovarian Carcinoma Tumour |
| RO82-W-1 | cell line derived from Thyroid Gland Carcinoma Tumour |
| ROS-50 | cell line derived from -666 |
| RPMI-6666 | cell line derived from Non-Cancerous Normal |
| RPMI-7951 | Human skin malignant melanoma cells that can be ordered from ATCC. This is a hyperdiploid human cell line with the modal chromosome number of 49, occurring in 24% of cells. Polyploid cells occurred at 22%, which is high. Cells are adherent, and were first harvested in 1971 from a metastatic site in a lymph node. |
| RPMI-8226 | cell line derived from Plasma Cell Myeloma Tumour |
| RPMI-8402 | cell line derived from T-Lymphoblastic Leukemia Tumour |
| RPMI-8866 | cell line derived from Chronic Myelogenous Leukemia Tumour |
| RS4-11 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| RT-112 | cell line derived from Bladder Carcinoma Tumour |
| RT4 | cell line derived from Bladder Carcinoma Tumour |
| RVH-421 | cell line derived from Melanoma Metastasis |
| RXF393 | cell line derived from Kidney Carcinoma Tumour |
| Saos-2 | cell line derived from Osteosarcoma Tumour |
| SAS | |
| SAT | cell line derived from -666 |
| SBC-1 | cell line derived from Small Cell Lung Carcinoma Tumour |
| SBC-3 | cell line derived from lung |
| SBC-5 | |
| SC-1 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| SCC-15 | cell line derived from Oral Cavity Carcinoma Tumour |
| SCC-25 | cell line derived from Oral Cavity Carcinoma Tumour |
| SCC-3 | |
| SCC-4 | cell line derived from Oral Cavity Carcinoma Tumour |
| SCC-9 | cell line derived from Oral Cavity Carcinoma Tumour |
| SCC90 | cell line derived from -666 |
| SCH | |
| SF126 | |
| SF268 | |
| SF295 | |
| SF539 | |
| SH-4 | cell line derived from Melanoma Tumour |
| SHP-77 | cell line derived from Small Cell Lung Carcinoma Tumour |
| SIG-M5 | cell line derived from Acute Myeloid Leukemia Tumour |
| SiHa | |
| SIMA | cell line derived from Neuroblastoma Metastasis |
| SISO | cell line derived from Cervical Carcinoma Tumour |
| SJRH30 | cell line derived from Rhabdomyosarcoma Metastasis |
| SJSA-1 | cell line derived from Osteosarcoma Tumour |
| SK-CO-1 | cell line derived from Colorectal Carcinoma Metastasis |
| SK-ES-1 | cell line derived from Ewing's Sarcoma Tumour |
| SK-GT-2 | cell line derived from -666 |
| SK-GT-4 | cell line derived from Esophageal Carcinoma Tumour |
| SK-HEP-1 | cell line derived from Hepatocellular Carcinoma Metastasis |
| SK-LMS-1 | cell line derived from Other Sarcomas Tumour |
| SK-LU-1 | cell line derived from Non-Small Cell Lung Carcinoma Tumour |
| SK-MEL-1 | cell line derived from Melanoma Metastasis |
| SK-MEL-2 | |
| SK-MEL-24 | cell line derived from Melanoma Metastasis |
| SK-MEL-28 | |
| SK-MEL-3 | cell line derived from Melanoma Metastasis |
| SK-MEL-30 | cell line derived from Melanoma Metastasis |
| SK-MEL-5 | cell line derived from Melanoma Metastasis |
| SK-MES-1 | cell line derived from Squamous Cell Lung Carcinoma Metastasis |
| SK-MG-1 | |
| SK-MM-2 | cell line derived from Plasma Cell Myeloma Tumour |
| SK-N-AS | |
| SK-N-DZ | cell line derived from Neuroblastoma Metastasis |
| SK-N-FI | cell line derived from Neuroblastoma Metastasis |
| SK-N-SH | |
| SK-OV-3 | cell line derived from Ovarian Carcinoma Metastasis |
| SK-PN-DW | cell line derived from Other Solid Cancers Tumour |
| SK-UT-1 | cell line derived from Other Sarcomas Tumour |
| SKG-IIIa | cell line derived from Cervical Carcinoma Tumour |
| SKM-1 | |
| SKN | cell line derived from Other Sarcomas Tumour |
| SKN-3 | cell line derived from -666 |
| SLVL | cell line derived from B-Cell Non-Hodgkin's Lymphoma Tumour |
| SN12C | |
| SNB75 | cell line derived from Glioblastoma Tumour |
| SNG-M | |
| SNU-1 | cell line derived from Gastric Carcinoma Tumour |
| SNU-16 | cell line derived from Gastric Carcinoma Metastasis |
| SNU-175 | cell line derived from Colorectal Carcinoma Metastasis |
| SNU-283 | cell line derived from Colorectal Carcinoma Metastasis |
| SNU-387 | cell line derived from Hepatocellular Carcinoma Tumour |
| SNU-398 | cell line derived from Hepatocellular Carcinoma Tumour |
| SNU-407 | cell line derived from Colorectal Carcinoma Metastasis |
| SNU-423 | cell line derived from Hepatocellular Carcinoma Tumour |
| SNU-449 | cell line derived from Hepatocellular Carcinoma Tumour |
| SNU-475 | cell line derived from Hepatocellular Carcinoma Tumour |
| SNU-5 | cell line derived from Gastric Carcinoma Metastasis |
| SNU-61 | cell line derived from Colorectal Carcinoma Metastasis |
| SNU-81 | cell line derived from Colorectal Carcinoma Tumour |
| SNU-C1 | cell line derived from Colorectal Carcinoma Metastasis |
| SNU-C2B | cell line derived from Colorectal Carcinoma Tumour |
| SNU-C5 | cell line derived from Colorectal Carcinoma Tumour |
| SR | |
| STS-0421 | cell line derived from -666 |
| SU-DHL-1 | cell line derived from T-Cell Non-Hodgkin's Lymphoma Metastasis |
| SU-DHL-10 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| SU-DHL-16 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| SU-DHL-4 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| SU-DHL-6 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| SU-DHL-8 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| SU8686 | cell line derived from Pancreatic Carcinoma Metastasis |
| SUIT-2 | cell line derived from Pancreatic Carcinoma Metastasis |
| SUP-B15 | cell line derived from B-Lymphoblastic Leukemia Tumour |
| SUP-B8 | cell line derived from haematopoietic_and_lymphoid_tissue |
| SUP-HD1 | cell line derived from Hodgkin's Lymphoma Unknown |
| SUP-M2 | cell line derived from T-Cell Non-Hodgkin's Lymphoma Tumour |
| SUP-T1 | cell line derived from T-Lymphoblastic Leukemia Metastasis |
| SW1088 | |
| SW1116 | |
| SW1271 | cell line derived from Small Cell Lung Carcinoma Tumour |
| SW13 | |
| SW1417 | |
| SW1463 | |
| SW156 | cell line derived from Kidney Carcinoma Tumour |
| SW1573 | |
| SW1710 | cell line derived from Bladder Carcinoma Tumour |
| SW1783 | cell line derived from Glioma Tumour |
| SW1990 | |
| SW48 | |
| SW620 | |
| SW626 | cell line derived from Colorectal Carcinoma Metastasis |
| SW684 | cell line derived from Other Sarcomas Tumour |
| SW756 | cell line derived from Cervical Carcinoma Tumour |
| SW780 | cell line derived from Bladder Carcinoma Tumour |
| SW837 | |
| SW872 | |
| SW948 | |
| SW954 | cell line derived from Other Solid Cancers Tumour |
| SW962 | |
| SW982 | |
| T-T | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| T24 | |
| T47D | |
| T84 | |
| T98G | Human, Caucasian, glioblastoma cell line. |
| TALL-1 | cell line derived from T-Lymphoblastic Leukemia Tumour |
| TC-71 | cell line derived from Ewing's Sarcoma Tumour |
| TCCSUP | cell line derived from Bladder Carcinoma Tumour |
| TE-1 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| TE-10 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| TE-11 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| TE-12 | |
| TE-15 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| TE-4 | cell line derived from Esophageal Squamous Cell Carcinoma Metastasis |
| TE-441-T | cell line derived from Rhabdomyosarcoma Tumour |
| TE-5 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| TE-6 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| TE-8 | cell line derived from Esophageal Squamous Cell Carcinoma Tumour |
| TE-9 | cell line derived from Esophageal Squamous Cell Carcinoma Metastasis |
| TGBC11TKB | cell line derived from Gastric Carcinoma Metastasis |
| TGBC1TKB | cell line derived from Biliary Tract Carcinoma Metastasis |
| TGBC24TKB | cell line derived from Biliary Tract Carcinoma Metastasis |
| TGW | |
| THP-1 | |
| TK | cell line derived from blood |
| TK10 | cell line derived from Kidney Carcinoma Tumour |
| TMK-1 | cell line derived from Gastric Carcinoma Unknown |
| TOV-112D | TOV-112D is a human epithelial cell line initiated in October of 1992 from a patient with early onset ovarian cancer. The patient was of French-Canadian descent with an unknown family history of ovarian cancer. |
| TOV-21G | cell line derived from Ovarian Carcinoma Tumour |
| TT | |
| TT2609-C02 | cell line derived from Thyroid Gland Carcinoma Tumour |
| TUR | |
| TYK-nu | |
| U-118-MG | cell line derived from Glioma Tumour |
| U-2-OS | cell line derived from Osteosarcoma Tumour |
| U-266 | cell line derived from Plasma Cell Myeloma Tumour |
| U-698-M | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| U-CH2 | cell line derived from bone |
| U031 | |
| U251 | |
| UACC-257 | |
| UACC-62 | |
| UACC-812 | cell line derived from Breast Carcinoma Tumour |
| UACC-893 | cell line derived from Breast Carcinoma Tumour |
| UM-UC-3 | cell line derived from Bladder Carcinoma Tumour |
| UMC-11 | cell line derived from Other Solid Cancers Tumour |
| UWB1.289 | cell line derived from Ovarian Carcinoma Tumour |
| VA-ES-BJ | cell line derived from Other Sarcomas Metastasis |
| VAL | |
| VCaP | |
| VMRC-LCD | cell line derived from Non-Small Cell Lung Carcinoma Unknown |
| VMRC-MELG | cell line derived from skin |
| VMRC-RCW | cell line derived from Kidney Carcinoma Unknown |
| VMRC-RCZ | cell line derived from Kidney Carcinoma Tumour |
| WIL2-NS | cell line derived from Non-Cancerous Tumour |
| WM-115 | cell line derived from Melanoma Tumour |
| WM1552C | cell line derived from Melanoma Tumour |
| WM278 | cell line derived from Melanoma Tumour |
| WM35 | |
| WM793B | cell line derived from Melanoma Metastasis |
| WSU-DLCL2 | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| WSU-NHL | cell line derived from B-Cell Non-Hodgkin's Lymphoma Metastasis |
| YAPC | cell line derived from Pancreatic Carcinoma Metastasis |
| YH-13 | |
| YKG-1 | cell line derived from Glioblastoma Tumour |
| YMB-1-E | cell line derived from Breast Carcinoma Metastasis |
| YT | cell line derived from Other Blood Cancers Metastasis |
| ZR-75-30 | cell line derived from Breast Carcinoma Metastasis |
